You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Low dose gemcitabine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer Trial in Seoul (Antiviral treatment in combination with low-dose gemcitabine)

Not yet recruiting
  • Gastric Cancer
  • Antiviral treatment in combination with low-dose gemcitabine
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 21, 2022

Breast Cancer, Breast Tumors Trial in Charlottesville (drug, device, other)

Recruiting
  • Breast Cancer
  • Breast Neoplasms
  • Charlottesville, Virginia
    University of Virginia
May 17, 2022

Ewing Sarcoma, Ewing-Like Sarcoma Trial in New York (LY2880070, Gemcitabine)

Recruiting
  • Ewing Sarcoma
  • Ewing-Like Sarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 18, 2022

Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Intensity Modulated Radiation Therapy
  • +3 more
  • (no location specified)
Jul 11, 2023

Leiomyosarcoma Trial in Santa Monica (Trabectedin)

Recruiting
  • Leiomyosarcoma
  • Santa Monica, California
    Sant P Chawla
Oct 13, 2022

Non Small Cell Lung Cancer Trial in Quzhou (Cisplatin / Carboplatin,Gemcitabine,Cindilimab)

Recruiting
  • Non Small Cell Lung Cancer
  • Cisplatin / Carboplatin，Gemcitabine，Cindilimab
  • Quzhou, Zhejiang, China
    Quzhou people's Hospital
Apr 2, 2022

Platinum-Sensitive Biliary Tract Cancer Trial (Cisplatin, Gemcitabine, Oxaliplatin)

Withdrawn
  • Platinum-Sensitive Biliary Tract Cancer
  • (no location specified)
May 27, 2022

Metastatic Pancreatic Cancer Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Cisplatin)

Recruiting
  • Metastatic Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreas Cancer
  • Non-Resectable Pancreas Carcinoma
  • Aalborg, Denmark
    Department of Oncology, Aalborg University Hospital
May 1, 2023

Metastatic Pancreatic Cancer, Pancreatic Cancer Trial in Worldwide (IMMU-107, , Gemcitabine)

Terminated
  • Metastatic Pancreatic Cancer
  • Pancreatic Cancer
  • Gilbert, Arizona
  • +64 more
Aug 12, 2021

Nasopharyngeal Carcinoma Trial in Guangzhou, Zhongshan, Nanning (IMRT and concurrent cisplatin, gemcitabine and cisplatin

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • IMRT and concurrent cisplatin
  • gemcitabine and cisplatin (Induction chemotherapy)
  • Guangzhou, Guangdong, China
  • +3 more
Jul 30, 2023

NSCLC Metastatic Trial (Gemcitabine Injectable Product)

Not yet recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Gemcitabine Injectable Product
  • (no location specified)
Mar 31, 2020

Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Aug 24, 2023

Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Apr 11, 2023

NSCLC Trial (Milciclib Dose: 150 mg/day Mode of administration: oral)

Not yet recruiting
  • NSCLC
  • Milciclib Dose: 150 mg/day Mode of administration: oral
  • (no location specified)
Dec 12, 2022

Appendicitis Acute Trial (Weight-adjusted low-dose contrast media paired with low-radiation dose abdomen CT)

Not yet recruiting
  • Appendicitis Acute
  • Weight-adjusted low-dose contrast media paired with low-radiation dose abdomen CT
  • (no location specified)
May 18, 2023

Pancreatic Cancer Trial in Philadelphia (PLDR)

Recruiting
  • Pancreatic Cancer
  • PLDR
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 18, 2022

Nasopharyngeal Carcinoma, Metastasis, Chemo Trial in Guangzhou (Triprilimab(JS001), Cisplatin, 5-Fluorouracil)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +4 more
  • Guangzhou, Guangdong, China
    Department of Radiation Oncology, Sun Yat-Sen University Cancer
May 16, 2021

Urothelial Carcinoma Bladder, Sperm Count, Low, Testis; Fibrosis Trial (Bacillus Calmette Guerin)

Not yet recruiting
  • Urothelial Carcinoma Bladder
  • +2 more
  • Bacillus Calmette Guerin
  • (no location specified)
Jan 18, 2023

Atrial Fibrillation, Anticoagulant Adverse Reaction, Stroke Trial (low-dose rivaroxaban, Standard-dose rivaroxaban)

Not yet recruiting
  • Atrial Fibrillation
  • +3 more
  • low-dose rivaroxaban
  • Standard-dose rivaroxaban
  • (no location specified)
Oct 25, 2023

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Aldesleukin
  • +9 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

Pancreatic Cancer Trial in Modena (LDR, Gem-based doublets, SBRT)

Recruiting
  • Pancreatic Cancer
  • LDR
  • +2 more
  • Modena, MO, Italy
    Azienda Ospedaliero-Universitaria Policlinico di Modena
Dec 8, 2022

Septic Shock Trial in Cairo (Normal saline, Methylene Blue low dose, Methylene Blue high dose)

Recruiting
  • Septic Shock
  • Normal saline
  • +2 more
  • Cairo, Egypt
    National Cancer Institute
Aug 15, 2023

Opioid Use Disorder Trial (buprenorphine/naloxone)

Not yet recruiting
  • Opioid Use Disorder
  • (no location specified)
Jul 10, 2023

Glioma Trial in Aviano (Pulsed low dose-rate radiotherapy (pLDRT))

Recruiting
  • Glioma
  • Pulsed low dose-rate radiotherapy (pLDRT)
  • Aviano, Pordenone, Italy
    IRCCS-Centro di Riferimento Oncologico (CRO) di Aviano
Sep 20, 2023